Alivus Life Sciences Limited (NSE:ALIVUS)
India
· Delayed Price · Currency is INR 1,033.60
+5.50 (0.53%)
At close: Apr 24, 2025
Alivus Life Sciences Revenue
Alivus Life Sciences had revenue of 6.42B INR in the quarter ending December 31, 2024, with 12.05% growth. This brings the company's revenue in the last twelve months to 22.74B, down -3.97% year-over-year. In the fiscal year ending March 31, 2024, Alivus Life Sciences had annual revenue of 22.83B with 5.64% growth.
Revenue (ttm)
22.74B
Revenue Growth
-3.97%
P/S Ratio
5.57
Revenue / Employee
11.29M
Employees
2,014
Market Cap
126.65B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |